Complex 24 (IC50 to EGFR = 29.1 nM) was revealed to be a promising antiproliferative agent against MCF-7 breast (IC50 = 17.3 μM) and HeLa cervical cancer cells (IC50 = 1.4 μM), with selectivity index values (EGFR-induced versus non-induced growth of the cell lines) higher than 6 and 3, respectively [85,86]. Here, EGFR is linked to cervical cancer.